drugset / Trial / NCT03275636
Haploidentical Donor vs mMUD in Hematological Malignancies
RandomizedParallel-groupOpen-labelTreatment
Summary
The goal of this trial is to compare the outcome after partially matched (single mismatch) unrelated donor transplantation with haploidentical transplantation in a randomized controlled setting.
Timeline
- Start
- 2018-01-01
- Primary completion
- 2024-04-13
- Completion
- 2024-04-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Peripheral blood stem cells | Cell therapy | — | — |